Aneurysm Aortic

4

Review clinical trials related to Aneurysm Aortic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients

This study examines adults with COL5A gene mutations to understand why some develop aortic aneurysms while others do not. Participants provide a small skin biopsy, and researchers analyze fibroblasts to evaluate collagen production, extracellular matrix organization, and connective-tissue signaling pathways. The goal is to identify biological differences that may explain variable vascular risk and support future personalized monitoring and treatment strategies.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: IRCCS Policlinico S. DonatoUpdated: Jul 2, 2026Locations: 1
Eligibility criteria

Subjects aged 18 and above [+2]

Corticosteroid or Steroids or Fluorochinolones treatment within six months befor... [+5]

Status: Not yet recruiting

Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Juxtarenal Abdominal Aortic Aneurysm

Juxta-renal abdominal aortic aneurysms (AAA) are challenging to treat with standard endovascular techniques (EVAR) due to their proximity to the renal arteries. Open surgical repair continues to be used in patients unsuitable for EVAR but carries a high risk of acute kidney injury (AKI), up to 24%. Postoperative AKI is a strong predictor of both short- and long-term cardiovascular mortality. The KDIGO criteria are used to better define and stage AKI. Pharmacological prevention strategies have shown limited effectiveness, prompting interest in ischemic preconditioning (IPC). Remote IPC has shown mixed results in cardiac and vascular surgery, depending on patient risk and protocols used. Local IPC, applied directly near the renal arteries, has shown promising renal protection in animal models. However, this technique has never been clinically tested in humans. We propose here a randomized trial to assess the efficacy of local IPC before suprarenal aortic clamping during open repair of juxta-renal AAA to reduce postoperative AKI.

Participants needed: 206
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: University Hospital, RouenUpdated: Jun 9, 2026Locations: 7
Eligibility criteria

Patients aged 18-85 years [+8]

Patients dependent from dialysis [+11]

Status: Recruiting

Strength Tracking From Wall Tichness Over Aortic Biomechanics (STORM)

The aim of the study is to analyse the resected portion of aneurysmatic ascending aorta in order to assess its strength to rupture, standardise the various measurements performed within the lab and try to correlate these qualitative results with quantitative results (regarding aortic diameter, valve morphology and aortic wall thickness).

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: IRCCS Policlinico S. DonatoUpdated: Mar 11, 2026Locations: 1
Eligibility criteria

Patients undergoing cardiac surgery for either aortic root and/or ascending aort...

Patients that have already undergone previous cardiac surgery; • Patients that p...

Status: Recruiting

Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies

The study objectives are to assess safety and effectiveness, measured acutely and at the 30-day visit after implantation of the Valiant Captivia physician fenestrated Stent Graft. Clinical utility measures throughout the procedure and until discharge will be assessed

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ceric SàrlUpdated: May 1, 2024Locations: 4
Eligibility criteria

Subject is at least 18 years of age. [+24]

Subject has an aneurysmal, tortuous, or atherosclerotic LSA. [+51]